5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coster, MJ; Davis, RA; Egbewande, FA; Levrier, C; Nelson, CC; Sadowski, MC; Tousignant, KD; White, JM | 1 |
| Cohen, MB; Glover, RA; Guseva, NV; Rokhlin, OW | 1 |
2 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and Prostatic Neoplasms
| Article | Year |
|---|---|
Identification of Gibberellic Acid Derivatives That Deregulate Cholesterol Metabolism in Prostate Cancer Cells.
Topics: Biological Products; Cell Line, Tumor; Cholesterol; Crystallography, X-Ray; Cytotoxins; Gibberellins; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Male; Prostatic Neoplasms | 2018 |
TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status.
Topics: Acetyl-CoA Carboxylase; Androgen Receptor Antagonists; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Death; Cell Line, Tumor; Cytochromes c; Dihydrotestosterone; Fatty Acids; Furans; Genes, p53; Humans; Introns; Lipids; Male; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neuropilin-1; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, Androgen | 2011 |